|
Sign In to gain access to subscriptions and/or personal tools.
|
Interleukin (IL)-10 attenuates lipopolysaccharide-induced IL-6 production via inhibition of I B- activity by Bcl-3
Jargalsaikhan Dagvadorj
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan, yokochi{at}aichi-med-u.ac.jp
Yoshikazu Naiki
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Gantsetseg Tumurkhuu
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Abu Shadat Mohammod Noman
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Imtiaz Iftekar-E-Khuda
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Naoki Koide
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Takayuki Komatsu
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Tomoaki Yoshida
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Takashi Yokochi
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
The inhibitory effect of interleukin-10 (IL-10), an anti-inflammatory cytokine, on lipopolysaccharide (LPS)-induced IL-6 production was characterized by simultaneous stimulation of RAW 264.7 cells with LPS and IL-10. The presence of IL-10 significantly inhibited LPS-induced IL-6 production at a transcriptional level. The expression of I B- , which promotes IL-6 production, was induced in response to LPS and it was definitely suppressed in the presence of IL-10. Further, IL-10 inhibited LPS-induced NF- B activation. A pharmacological inhibitor of NF- B prevented LPS-induced I B- expression, suggesting that IL-10 might inhibit LPS-induced I B- expression via the inactivation of NF- B. In LPS- and IL-10-stimulated cells, the expression of Bcl-3 that inhibits NF- B activation was significantly augmented. Introduction of Bcl-3 siRNA abolished IL-10-mediated I B- inhibition. In the presence of Bcl-3, siRNA IL-10 failed to inhibit LPS-induced IL-6 production. Therefore, it was suggested that Bcl-3 induced by IL-10 might reduce LPS-induced I B- activity via inactivation of NF- B and that reduced I B- activity failed to promote LPS-induced IL-6 production.
Key Words: Bcl-3 IL-10 IL-6 LPS I B-
This version was published on August
1, 2009
Innate Immunity, Vol. 15, No. 4,
217-224 (2009)
DOI: 10.1177/1753425909103738

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|